Original Source(s)
Related Content
ACP Suggests First-Line Obesity Drugs
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026
-
5 min
FDA Approves Treg Cell Therapy
A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.
July 1, 2026
-
2 min
Pregnancy Risks With First Trimester GLP-1 Continuation
Claims-based target trial emulation found no clear association between continued GLP-1 receptor agonist use in early pregnancy and nonlive birth, fetal growth abnormalities, or major congenital malformations.
June 17, 2026
-
3 min